Alacizumab pegol: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 55: | Line 55: | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 16:45, 22 March 2025
| Alacizumab pegol | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 934216-54-3 |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | |
Alacizumab pegol is an antineoplastic agent. Chemically, it is a pegylated F(ab')2 fragment of a monoclonal antibody.<ref>International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.</ref>
References[edit]
<references/>
| Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!
